Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation-Reference-Cited by-同舟云学术

Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation

Published:2016-12-10 Issue:1 Volume:21 Page:91-101
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Amodio Nicola¹,D’Aquila Patrizia²,Passarino Giuseppe²,Tassone Pierfrancesco¹³,Bellizzi Dina²

Affiliation:

1. Department of Experimental and Clinical Medicine, Magna Graecia University, Catanzaro, Italy

2. Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, Italy

3. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, US

Funder

Associazione Italiana per la Ricerca sul Cancro

Seventh Framework Programme

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2016.1266339

Reference117 articles.

1. The Genetic Architecture of Multiple Myeloma

2. The role of epigenetics in the biology of multiple myeloma

3. Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies

4. Possible roles for activating RAS mutations in the MGUS to MM transition and in the intramedullary to extramedullary transition in some plasma cell tumors

5. Cell cycle genes co-expression in multiple myeloma and plasma cell leukemia

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma;Experimental Hematology & Oncology;2023-08-10

2. Lysin (K)-Specific Demethylase 1 Inhibition Enhances Proteasome Inhibitor Response and Overcomes Drug Resistance in Multiple Myeloma;2023-05-18

3. Natural Agents as Novel Potential Source of Proteasome Inhibitors with Anti-Tumor Activity: Focus on Multiple Myeloma;Molecules;2023-02-02

4. Hydroxychloroquine: Chemistry and Medicinal Applications;HETEROCYCLES;2023

5. Multiple myeloma, a quintessential malignant disease of aging: a geroscience perspective on pathogenesis and treatment;GeroScience;2022-12-12